Jorge Martin Arana

PhD at the Oncology Unit of the INCLIVA Biomedical Research Institute. Bioinformatician, biotechnologist and a friend :)

[Francisco Gimeno-Valiente @F_gimenoval]

What an amazing friend to be proud of! You did it, Noe!
Such an incredible recognition from the scientific community, so well deserved. Everyone in your group loves you!!! 💖💖
Thank you for everything!

[INCLIVA @incliva_iis]

🔝 El trabajo ‘ctDNA clearance after induction therapy as predictor of response to radical chemoradiotherapy in locally advanced head and neck cancer’, liderado por la investigadora de INCLIVA Gema Bruixola, ha sido reconocido con el Best Poster Award en el congreso #ICHNO26

[ISCB SC RSG-Spain @RSGSpain]

What if we could detect colon cancer relapse before it’s clinically visible?
Whole-exome, tumor-agnostic ctDNA profiling dramatically improves MRD detection, reveals immune evasion in MSS colon cancer, and opens the door to precision therapies guided by patient-derived organoids.

[Noelia Tarazona @TarazonaNoelia]

🤝An international collaboration with @aparna1024 and our CRC team @incliva_iis @GVAsanitat

[Noelia Tarazona @TarazonaNoelia]

💣 When used at a single timepoint, tumor-informed and tumor-agnostic ctDNA🩸assays show similar performance; however, with serial monitoring, tumor-informed assays clearly outperform tumor-agnostic approaches in sensitivity for recurrence❗️

🔗https://t.co/hmUtEu9H9n

🩸🩸🩸🩸

[Gema Bruixola @BruixolaGema]

¡Gracias a @_SEOM por otorgarme uno de los 10 Premios de Tesis Doctoral y premiar nuestro estudio como una de las 5 mejores Comunicaciones Orales #SEOM25. Una gran motivación para seguir investigando en cáncer de cabeza y cuello 🧬 Gracias @TarazonaNoelia @KokeMartin @incliva_iis

[Jorge Martin Arana @KokeMartin]

Ha sido un placer participar en esta gran iniciativa del @nortecastilla. Muchas gracias a @Lauranegrol por la entrevista y por dar voz al talento local! #LaLigaDelTalento

[El Norte de Castilla @nortecastilla]

El científico vallisoletano que investiga en Londres: «Cada tipo de cáncer es una enfermedad diferente» https://t.co/tH4ffCw5IC

[El Norte de Castilla @nortecastilla]

El científico vallisoletano que investiga en Londres: «Cada tipo de cáncer es una enfermedad diferente» https://t.co/tH4ffCw5IC

[Noelia Tarazona @TarazonaNoelia]

📌New in @ESMO_Open: 🎯Tumor Boards can guide matched therapies for ESCAT II-III alterations. Patients had median OS 31 vs 11 months.

🏥Study conducted at @incliva_iis @GVAsanitat, led by @Desam_Roda @ValeGambardella

🔗https://t.co/RS6dAbL8uS

[Charles Swanton @CharlesSwanton]

Proud to share our first TRACERx cancer study integrating epigenomics + genomics in NSCLC as co-drivers of tumor evolution.
Led by not me but by the wonderful @NnennayaKanu, @F_gimenoval, @ccastignani6, @VanLooLab

[Noelia Tarazona @TarazonaNoelia]

🔥New in @NatureGenet by @F_gimenoval during his postdoc at @ucl under @NnennayaKanu @CharlesSwanton 🔝

📌Genomic & epigenomic drivers converge in lung cancer. New methylation dN/dS + AllChAT reveal chromatin-driven dosage compensation.
🔗https://t.co/9rswZxbSsK

[Mario Balsa @MarioBalsaMD]

📢 New in @NatureCancer: WES-based tumor-agnostic ctDNA analysis improves MRD detection & reveals immune escape as key in localized colon cancer relapse.

https://t.co/k4OdothI4N

🎯 Precision meets persistence. MRD, meet your nemesis.

Congrats to @KokeMartin @TarazonaNoelia and all the team! 🎉

@OncoAlert #OncoAlertAF @_SEOM @GrupoTTD

[Jorge Martin Arana @KokeMartin]

Very proud of this recognition and of the incredible team behind it! Honored to see our work featured on the cover of @NatureCancer

[Noelia Tarazona @TarazonaNoelia]

🔥 We got the cover of the June issue of @NatureCancer with our paper! 🌟 A huge honor and a recognition of the team’s hard work.

🔗 https://t.co/IyvDXz7vC5

📄 See https://t.co/l79etJ9lgH

[Noelia Tarazona @TarazonaNoelia]

🔥 We got the cover of the June issue of @NatureCancer with our paper! 🌟 A huge honor and a recognition of the team’s hard work.

🔗 https://t.co/IyvDXz7vC5

📄 See https://t.co/l79etJ9lgH

[Noelia Tarazona @TarazonaNoelia]

💥Proud of our team for presenting cutting-edge work on ctDNA🩸and tumor-immune profiling in CRC at #EACR2025!

🔬From resistance mechanisms to new immunotherapy strategies - science made in Valencia @incliva_iis 🇪🇸✨
🔝@_belenmartinez @dgcamblor @GarciaMicoB

[Clara Marzá @klaram]

Enorme la labor de @TarazonaNoelia y su equipo del @incliva_iis 💙

[Informativos Telecinco @informativost5]

Nuevo avance científico marca España: un test de sangre permitirá detectar el riesgo de recaída del cáncer colorrectal https://t.co/Jtr4bcSY3y

[Noelia Tarazona @TarazonaNoelia]

Este TEAM lo ha hecho posible❤️👇, a la guía de mi mentor Andrés Cervantes y al apoyo de becas @_SEOM @GrupoTTD @SaludISCIII

[Noelia Tarazona @TarazonaNoelia]

Un test ideado en España permite detectar qué pacientes de cáncer de colon recaerán tras la cirugía https://t.co/HSGLDAxHjJ a través de @elperiodico

[Informativos Telecinco @informativost5]

Una investigación liderada por el Hospital Clínico de Valencia mejora la detección de micrometástasis del cáncer de colon https://t.co/nyrbLxw5zA